Vancouver, British Columbia--(Newsfile Corp. - December 19, 2014) - CBD MED Research Corp. (TSXV: CBM.H) ("CBM" or the "Company"): Further to the news release dated November 14, 2014 regarding the private placement of 5,000,000 units priced at 0.06 cents as a unit to include a warrant for twelve months with a conversion term into one common share at 0.08 cents.
The Company is proceeding and expects to file the first tranche during the first week of January 2015.
On behalf of the Board of Directors,
CBD Med Research Corp.
"Gary F. Zak"
President, CEO
Email: gzak1@shaw.ca
Tel: 604-802-7551
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, including the likelihood of commercial mining and possible future financings are forward-looking statements. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those in forward-looking statements include unsuccessful business , changes in forecast prices, changes in the availability of funding for proposed business plans, unanticipated changes in key management personnel and general economic conditions. Accordingly the actual events may differ materially from those projected in the forward-looking statements. For more information on the Company and the risks and challenges of its business, investors should review the Company's annual filings that are available at www.sedar.com.
*THIS NEWS RELEASE IS NOT FOR DISSEMINATION IN THE UNITED STATES*
